Ozempic (semaglutide) is designed to be used long-term, potentially indefinitely, for weight management. There is no standard “course” you complete and then stop. Clinical trials lasting up to four years show that weight loss is sustained only as long as people keep taking the medication, and most weight returns within a year of stopping.
Why There’s No Set End Date
Obesity is treated as a chronic condition, similar to high blood pressure or type 2 diabetes. Just as you wouldn’t stop blood pressure medication once your numbers improve, semaglutide is meant to be continued to maintain its effects. The drug works by mimicking a hormone that suppresses appetite and slows digestion. Those effects last only as long as the medication is in your system.
Data from the SELECT trial confirms that weight loss with semaglutide continues for roughly 65 weeks, then holds steady for up to four years of ongoing use. Importantly, people who stayed on the drug for four years also had fewer serious adverse events than those on placebo, regardless of their starting weight. So the safety profile doesn’t appear to worsen with extended use.
What Happens When You Stop
The evidence here is stark. In the STEP 1 trial extension, participants who stopped semaglutide after about 68 weeks regained two-thirds of the weight they had lost within one year. On average, they regained 11.6 percentage points of their prior weight loss. Improvements in blood sugar, cholesterol, and blood pressure also reversed along a similar timeline.
This isn’t a willpower issue. When you lose weight, your body’s hunger hormones shift: the hormone that signals fullness drops, and the hormone that drives hunger rises. Semaglutide overrides those signals by acting on appetite centers in the brain. Once you stop taking it, that override disappears. Some effects reverse quickly. The slowed stomach emptying that helps you feel full longer returns to normal relatively fast. The hormonal shifts take longer to fully rebound, but behavioral patterns and increased appetite begin reasserting themselves within weeks.
Your body may also mount a counter-regulatory response after prolonged use of the drug. Long-acting versions like semaglutide can trigger the brain to upregulate hunger-promoting signals, which stay active once the medication is withdrawn. This can make post-discontinuation appetite feel even stronger than it was before treatment.
The Typical Timeline on Treatment
The first 16 to 20 weeks are a dose escalation phase. You start at a low dose (0.25 mg weekly) and increase every four weeks, stepping up through 0.5 mg, 1 mg, and 1.7 mg before reaching the target maintenance dose of 2.4 mg. This gradual ramp-up is designed to minimize gastrointestinal side effects like nausea, which are most common early on. If a particular dose causes problems, your prescriber may hold at that level for an extra four weeks before increasing again.
Most active weight loss happens during the first 60 to 65 weeks. After that, weight typically stabilizes at the new lower level as long as you continue the medication. In the STEP 4 trial, people who continued semaglutide after the initial 20-week period lost an additional 7.9% of their body weight over the following 48 weeks. Those switched to placebo gained back 6.9% over the same period, despite continuing the same lifestyle changes. The medication, not the lifestyle intervention alone, was driving the sustained loss.
Can You Use a Lower Maintenance Dose?
This is a common question, especially given the cost of the medication. Current prescribing guidelines set 2.4 mg as the maintenance dose for weight management. If you can’t tolerate that dose, a temporary step-down to 1.7 mg for four weeks is recommended before trying to return to the full dose. If the full dose remains intolerable, the guidance is to discontinue rather than stay on a lower dose indefinitely.
In practice, some prescribers do keep patients on lower doses once they’ve reached a goal weight, though this approach hasn’t been studied as rigorously. The clinical trials that demonstrated sustained weight loss all used the full 2.4 mg maintenance dose, so there’s limited data on whether a reduced dose provides the same long-term protection against regain.
Reasons You Might Stop Earlier
Not everyone stays on semaglutide for years. In the SELECT trial, discontinuation rates were higher with semaglutide than placebo, and people with lower BMIs were more likely to stop. The most common reasons include persistent gastrointestinal side effects (nausea, vomiting, diarrhea, constipation), cost or insurance changes, and personal preference.
If you’re considering stopping, the research suggests planning for it rather than stopping abruptly. The weight regain data makes clear that maintaining lifestyle habits alone, while valuable, typically isn’t enough to hold onto the full amount of weight lost on the medication. Some people accept partial regain as a trade-off. Others use the time on medication to build exercise habits and dietary patterns that may blunt, though not eliminate, the rebound.
The Bottom Line on Duration
Semaglutide for weight loss is not a short-term prescription with a built-in stop date. The clinical evidence consistently shows that stopping leads to significant weight regain, typically within 12 months. For people who tolerate the medication well and can access it consistently, the current medical framework treats it as ongoing therapy. Four-year safety data is reassuring, with no increase in serious adverse events compared to placebo. The real constraint for most people isn’t a medical timeline but a practical one: whether they can sustain access to the medication over years or decades.